ZIMMER BIOMET HOLDINGS, INC. Funds and ETFs Zimmer Biomet Holdings, Inc.
Equities
ZBH
US98956P1021
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.8 USD | -1.17% |
|
+0.35% | -1.60% |
| Apr. 15 | Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept | MT |
| Apr. 04 | Zimmer Biomet Partners with Three Pickleball Organizations in US | MT |
ETFs positioned on Zimmer Biomet Holdings, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 14,021 M€ | +3.35% | ||
| 2.33% | 6 M€ | +16.84% | - | |
| 1.04% | 16 M€ | -7.62% | ||
| 0.77% | 18 M€ | +3.04% | - | |
| 0.72% | 2 M€ | +5.19% | ||
| 0.69% | 4,592 M€ | +11.18% | ||
| 0.63% | 1 M€ | +11.94% | - | |
| 0.63% | 13 M€ | -.--% | - | |
| 0.63% | 3 M€ | +7.32% | - | |
| 0.52% | 92 M€ | +0.06% | - | |
| 0.52% | 4 M€ | +20.15% | ||
| 0.42% | 8 M€ | 0.00% | ||
| 0.29% | 469 M€ | -2.05% | - | |
| 0.29% | 3,859 M€ | +18.82% | - | |
| 0.27% | 9 M€ | -.--% | - | |
| 0.25% | 2 M€ | +20.44% | - | |
| 0.25% | 5 M€ | -72.95% | - | |
| 0.25% | 20 M€ | -.--% | - | |
| 0.23% | 1,006 M€ | -.--% | - | |
| 0.23% | 414 M€ | +9.07% | - | |
| 0.22% | 322 M€ | +13.88% | - | |
| 0.22% | 29 M€ | -.--% | - | |
| 0.16% | 26 M€ | +16.85% | - | |
| 0.16% | 219 M€ | +17.17% | - | |
| 0.16% | 1,448 M€ | -.--% | - | |
| 0.14% | 40 M€ | -.--% | ||
| 0.13% | 736 M€ | +5.85% | ||
| 0.13% | 9 M€ | +2.77% | - | |
| 0.12% | 330 M€ | -.--% | - | |
| 0.12% | 2 M€ | +14.69% | - | |
| 0.12% | 8 M€ | +3.15% | - | |
| 0.12% | 33 M€ | +0.34% | - | |
| 0.12% | 18 M€ | +3.15% | - | |
| 0.11% | 10 M€ | +5.10% |
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows:
- reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%);
- surgical products and traumatology equipment (22.1%);
- dental, spinal and craniomaxillofacial implants (12.8%);
- other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation.
At the end of 2021, the group had approximately 30 production sites worldwide.
Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
2024-05-02
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
121.2
USD
Average target price
137.1
USD
Spread / Average Target
+13.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.60% | 24.9B | |
| -2.92% | 185B | |
| -3.80% | 107B | |
| -5.48% | 67.55B | |
| +11.22% | 54.6B | |
| +16.74% | 47.42B | |
| +3.86% | 42.24B | |
| +4.56% | 28.24B | |
| +1.64% | 26.42B | |
| +12.40% | 25.66B |
- Stock Market
- Equities
- ZBH Stock
- Funds and ETFs Zimmer Biomet Holdings, Inc.
